Ahmad Ali H, Brown Brandon D, Andersen Clark R, Mahadeo Kris M, Petropolous Demetrios, Cortes José A, Razvi Shehla, Gardner Mary Katherine, Ewing Linette J, Mejia Rodrigo E
Pediatric Critical Care Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Pediatric Oncology Fellowship Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Oncol. 2021 Dec 14;11:770523. doi: 10.3389/fonc.2021.770523. eCollection 2021.
The use of flexible bronchoscopy (FB) with bronchoalveolar lavage (BAL) to diagnose and manage pulmonary complications has been shown to be safe in adult cancer patients, but whether its use is safe in pediatric cancer patients remains unclear. Thus, to describe the landscape of FB outcomes in pediatric cancer patients and to help define the populations most likely to benefit from the procedure, we undertook a retrospective review of FBs performed in patients younger than 21 years treated at our institution from 2002 to 2017. We found that a greater volume of total fluid instilled during BAL was significantly associated with increased probabilities of positive BAL culture (p=0.042), positive bacterial BAL culture (p=0.037), and positive viral BAL culture (p=0.0496). In more than half of the FB cases, findings resulted in alterations in antimicrobial treatment. Our study suggests that for pediatric cancer patients, FB is safe, likely provides diagnostic and/or therapeutic benefits, and has implications for treatment decisions.
使用可弯曲支气管镜(FB)联合支气管肺泡灌洗(BAL)来诊断和处理肺部并发症,已被证明在成年癌症患者中是安全的,但在儿科癌症患者中使用是否安全仍不清楚。因此,为了描述儿科癌症患者FB的结果情况,并帮助确定最可能从该操作中受益的人群,我们对2002年至2017年在我们机构接受治疗的21岁以下患者所进行的FB进行了回顾性研究。我们发现,BAL期间注入的总液体量增加与BAL培养阳性(p = 0.042)、细菌BAL培养阳性(p = 0.037)和病毒BAL培养阳性(p = 0.0496)的概率增加显著相关。在超过一半的FB病例中,检查结果导致了抗菌治疗的改变。我们的研究表明,对于儿科癌症患者,FB是安全的,可能提供诊断和/或治疗益处,并对治疗决策有影响。